Generated by GPT-5-mini| EMBO Conference | |
|---|---|
| Name | EMBO Conference |
| Status | Active |
| Genre | Scientific conference |
| Frequency | Annual and recurring |
| Venue | Various |
| Location | Europe and international |
| Country | Multiple |
| First | 1964 |
| Organizer | European Molecular Biology Organization |
EMBO Conference
The EMBO Conference is a recurrent series of scientific meetings organized by the European Molecular Biology Organization that convenes researchers in molecular biology, cell biology, genetics, biochemistry, and allied fields. The meetings foster exchanges among investigators from institutions such as the European Molecular Biology Laboratory, Max Planck Society, Wellcome Trust Sanger Institute, Imperial College London, and Karolinska Institutet and attract participants supported by funders including the European Research Council, Human Frontier Science Program, National Institutes of Health, and Gordon and Betty Moore Foundation.
EMBO Conferences bring together principal investigators, postdoctoral researchers, and graduate students from organizations like Cold Spring Harbor Laboratory, Harvard University, Massachusetts Institute of Technology, University of Cambridge, University of Oxford, ETH Zurich, École Normale Supérieure, CNRS, and Max Planck Institute for Molecular Cell Biology and Genetics to present results across topics such as DNA replication, RNA splicing, protein folding, signal transduction, and developmental biology. Sessions often feature invited speakers from awardees of prizes such as the Nobel Prize in Physiology or Medicine, Lasker Award, EMBO Gold Medal, Wolf Prize, and Breakthrough Prize in Life Sciences as well as rising investigators affiliated with centers like Francis Crick Institute, Weizmann Institute of Science, Johns Hopkins University, and Utrecht University.
The conference series traces institutional roots to early meetings convened by founders of European Molecular Biology Organization and partners like Cavendish Laboratory and Pasteur Institute during the 1960s, evolving alongside milestones such as the establishment of the European Molecular Biology Laboratory in the 1970s and the advent of technologies from Sanger sequencing to CRISPR–Cas9. Over decades the meetings expanded to include satellite symposia co-organized with entities including the Gordon Research Conferences, Society for Neuroscience, American Society for Cell Biology, and Federation of European Biochemical Societies, reflecting shifts seen at events like the Cold Spring Harbor Symposia and the Keystone Symposia on Molecular and Cellular Biology.
Governance is steered by elected members of European Molecular Biology Organization and advisory committees composed of scientists from institutions such as Max Planck Institutes, University College London, ETH Zurich, Karolinska Institutet, University of California, San Francisco, and Stanford University. Scientific programming is planned by convenors drawn from departments at Princeton University, Yale University, University of Heidelberg, McGill University, and Seoul National University with administrative support from offices linked to EMBL Grenoble and collaboration with funders such as Wellcome Trust and national agencies like the Agence Nationale de la Recherche and the Deutsche Forschungsgemeinschaft.
Typical formats mirror those of the Gordon Research Conferences and Keystone Symposia with plenary lectures, minisymposia, poster sessions, and workshops on experimental techniques pioneered at labs like Eli Lilly Research Laboratories, Pfizer Cambridge Research, and Genentech. Themes rotate across focal areas including chromatin remodeling, single-cell sequencing, synthetic biology, neurobiology, stem cell biology, proteomics, structural biology, metabolomics, and systems biology, featuring methodologies from cryo-electron microscopy, super-resolution microscopy, next-generation sequencing, and mass spectrometry.
Noteworthy gatherings have spotlighted breakthroughs associated with laboratories of figures such as Francis Crick, Sydney Brenner, Ada Yonath, Emmanuelle Charpentier, and Jennifer Doudna, and hosted topic-specific symposia on mechanisms illuminated by research at Zentner Lab, Drew Endy Lab, George Church Lab, Parker Institute, and Broad Institute. Special sessions have been held in collaboration with organizations like European Research Council panels, the Human Frontier Science Program Organization, and thematic meetings modeled on the Asilomar Conference on Recombinant DNA.
EMBO Conferences have accelerated dissemination of seminal findings connected to projects at Sanger Institute, Allen Institute for Brain Science, European Bioinformatics Institute, Institut Pasteur, Barcelona Institute for Science and Technology, and Institut Curie, influencing directions in translational research tied to institutions such as Karolinska University Hospital, Mayo Clinic, University of Tokyo Hospital, and Ragon Institute. Outcomes include collaborations leading to patents registered at offices like the European Patent Office and clinical translations supported by partnerships with GlaxoSmithKline, Novartis Institutes for BioMedical Research, and Roche.
Attendance is competitive; program committees select speakers and fellows from applicant pools associated with universities including University of Edinburgh, Trinity College Dublin, University of Barcelona, Heidelberg University Hospital, and research institutes like Friedrich Miescher Institute and Instituto Gulbenkian de Ciência. Funding mechanisms provide travel fellowships and childcare grants via sponsors such as the Wellcome Trust, European Molecular Biology Laboratory, EMBO Fellowship Programme, Marie Skłodowska-Curie Actions, and national research councils including the National Science Foundation and Swiss National Science Foundation.